GlaxoSmithKline Pharmaceuticals P/E Ratio
GlaxoSmithKline Pharmaceuticals (GLAXO) P/E ratio is 44.42 (High), EPS (TTM) ₹61.15, current price ₹2838.80 on NSE vs historical average P/E of 40.05 (66.7th percentile) — Very High - High growth expectations or significantly overvalued. Also explore GLAXO price movement history to track price trends across different timeframes.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
GLAXO P/E Ratio — Valuation Signal & Historical Context
GlaxoSmithKline Pharmaceuticals P/E 44.42 vs historical average 40.05, range 17.35–55.72 — signal: Overvalued.
- Stock appears overvalued with PE of 44.42, suggesting caution for new investments
- Trading at discount to sector average PE of 56.83
GlaxoSmithKline Pharmaceuticals P/E Ratio Historical Trend
GLAXO annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 44.42 vs historical average 40.05. For live price, revenue and the complete fundamental profile, see GlaxoSmithKline Pharmaceutical share price chart.
GLAXO Historical P/E Ratio — EPS, Year-End Price & Valuation
GlaxoSmithKline Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 37.69 | 59.23 | ₹2232.10 | NSE | High |
| 2024 | 38.74 | 50.37 | ₹1951.55 | NSE | High |
| 2023 | 35.4 | 37.18 | ₹1316.30 | NSE | High |
| 2022 | 17.35 | 100.13 | ₹1737.15 | NSE | Moderate |
| 2021 | 55.72 | 28.92 | ₹1611.50 | NSE | High |
| 2020 | 55.39 | 29.46 | ₹1631.85 | NSE | High |
GLAXO vs Healthcare Peers — P/E Ratio Comparison
GlaxoSmithKline Pharmaceuticals P/E 44.42 vs Healthcare average 56.83, median 31.66 — range 1.99–747.21.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |